Ictus Traslacional
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (12)
2023
-
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome
Neurology, Vol. 100, Núm. 23, pp. E2386-E2397
2022
-
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort
Neurology, Vol. 99, Núm. 12, pp. E1299-E1313
-
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131
-
Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score
Neurology, Vol. 98, Núm. 5, pp. E518-E532
2021
-
Clinical characteristics and outcomes of thymoma-associated myasthenia gravis
European Journal of Neurology, Vol. 28, Núm. 6, pp. 2083-2091
2020
2019
-
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 5, pp. 576-585
2018
-
Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations
Journal of Medical Genetics, Vol. 55, Núm. 12, pp. 814-823
2017
-
Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain
Scientific Reports, Vol. 7, Núm. 1
2015
-
Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain
Brain
-
Myasthenia gravis: Descriptive analysis of life-threatening events in a recent nationwide registry
European Journal of Neurology, Vol. 22, Núm. 7, pp. 1056-1061
-
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e149